Los Angeles Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,617
Closed -$400K 1735
2021
Q1
$400K Hold
2,617
﹤0.01% 1314
2020
Q4
$409K Sell
2,617
-130
-5% -$20.3K ﹤0.01% 1282
2020
Q3
$314K Sell
2,747
-38,382
-93% -$4.39M ﹤0.01% 1260
2020
Q2
$4.62M Buy
41,129
+3,703
+10% +$416K 0.02% 415
2020
Q1
$3.36M Sell
37,426
-80
-0.2% -$7.18K 0.02% 414
2019
Q4
$4.06M Hold
37,506
0.02% 468
2019
Q3
$3.67M Buy
37,506
+9,565
+34% +$937K 0.02% 478
2019
Q2
$3.66M Sell
27,941
-1,370
-5% -$179K 0.02% 508
2019
Q1
$3.96M Sell
29,311
-4,702
-14% -$636K 0.02% 481
2018
Q4
$3.31M Sell
34,013
-24,733
-42% -$2.41M 0.02% 438
2018
Q3
$8.17M Sell
58,746
-11,254
-16% -$1.56M 0.04% 368
2018
Q2
$8.69M Sell
70,000
-10,818
-13% -$1.34M 0.05% 377
2018
Q1
$9.01M Sell
80,818
-46,570
-37% -$5.19M 0.05% 334
2017
Q4
$15.2M Buy
127,388
+50,162
+65% +$6M 0.08% 269
2017
Q3
$10.8M Buy
77,226
+68,579
+793% +$9.62M 0.06% 300
2017
Q2
$1.05M Sell
8,647
-76,941
-90% -$9.36M 0.01% 742
2017
Q1
$10.4M Sell
85,588
-32,009
-27% -$3.88M 0.08% 293
2016
Q4
$14.4M Sell
117,597
-1,093
-0.9% -$134K 0.11% 236
2016
Q3
$14.5M Buy
118,690
+116,862
+6,393% +$14.3M 0.12% 232
2016
Q2
$213K Hold
1,828
﹤0.01% 1143
2016
Q1
$254K Hold
1,828
﹤0.01% 1001
2015
Q4
$349K Hold
1,828
﹤0.01% 947
2015
Q3
$286K Sell
1,828
-1,660
-48% -$260K ﹤0.01% 1032
2015
Q2
$631K Sell
3,488
-31
-0.9% -$5.61K 0.01% 884
2015
Q1
$610K Sell
3,519
-400
-10% -$69.3K 0.01% 882
2014
Q4
$725K Buy
3,919
+100
+3% +$18.5K 0.01% 734
2014
Q3
$633K Buy
3,819
+1,890
+98% +$313K 0.01% 714
2014
Q2
$301K Sell
1,929
-60,396
-97% -$9.42M ﹤0.01% 1028
2014
Q1
$9.48M Buy
62,325
+60,525
+3,363% +$9.21M 0.1% 238
2013
Q4
$239K Sell
1,800
-996
-36% -$132K ﹤0.01% 1165
2013
Q3
$325K Sell
2,796
-23,307
-89% -$2.71M ﹤0.01% 1057
2013
Q2
$2.41M Buy
+26,103
New +$2.41M 0.03% 423